AAAAAA

   
Results: 1-16 |
Results: 16

Authors: RICHARDS JP STICKELMEYER MP FLORA DB CHANCE RE FRANK BH DEFELIPPIS MR
Citation: Jp. Richards et al., SELF-ASSOCIATION PROPERTIES OF MONOMERIC INSULIN ANALOGS UNDER FORMULATION CONDITIONS, Pharmaceutical research, 15(9), 1998, pp. 1434-1441

Authors: CHANCE RE FRANK BH RADZIUK JM DIMARCHI RD
Citation: Re. Chance et al., DISCOVERY AND DEVELOPMENT OF INSULIN LISPRO, Medicamentos de actualidad, 34, 1998, pp. 1-9

Authors: WILLIAMS AJK BINGLEY PJ CHANCE RE GALE EAM
Citation: Ajk. Williams et al., COULD EPITOPE MASKING EXPLAIN WHY PROINSULIN AUTOANTIBODIES ARE LESS CLOSELY ASSOCIATED WITH IDDM THAN INSULIN AUTOANTIBODIES, Diabetologia, 41, 1998, pp. 41-41

Authors: BOWSHER RR LYNCH RA BROWNAUGSBURGER P SANTA PF LEGAN WE CHANCE RE
Citation: Rr. Bowsher et al., A SENSITIVE RADIOIMMUNOASSAY FOR THE SPECIFIC DETERMINATION OF INSULIN LISPRO, Diabetes, 47, 1998, pp. 370-370

Authors: SLIEKER LJ BROOKE GS DIMARCHI RD FLORA DB GREEN LK HOFFMANN JA LONG HB FAN L SHIELDS JE SUNDELL KL SURFACE PL CHANCE RE
Citation: Lj. Slieker et al., MODIFICATIONS IN THE B10-REGION AND B26-30-REGION OF THE B-CHAIN OF HUMAN INSULIN ALTER AFFINITY FOR THE HUMAN IGF-I-RECEPTOR MORE THAN FORTHE INSULIN-RECEPTOR, Diabetologia, 40, 1997, pp. 54-61

Authors: RADZIUK JM DAVIES JC PYE WS SHIELDS JE DIMARCHI RD CHANCE RE
Citation: Jm. Radziuk et al., BIOAVAILABILITY AND BIOEFFECTIVENESS OF SUBCUTANEOUS HUMAN INSULIN AND 2 OF ITS ANALOGS - LYS(B28)PRO(B29)-HUMAN INSULIN AND ASP(B10)LYS(B28)PRO(B29)-HUMAN INSULIN - ASSESSED IN A CONSCIOUS PIG MODEL, Diabetes, 46(4), 1997, pp. 548-556

Authors: HAMEL FG SIFORD GL FRANK BH CHANCE RE DUCKWORTH WC
Citation: Fg. Hamel et al., B10-ASP INSULIN (B10), BUT NOT B28-LYS, B29-PRO INSULIN (LYSPRO), IS RESISTANT TO METABOLISM BY HEPATOCYTES AND INSULIN DEGRADING ENZYME (IDE), Diabetes, 46, 1997, pp. 785-785

Authors: GEHLERT DR SCHOBER DA BEAVERS L GADSKI R HOFFMAN JA SMILEY DL CHANCE RE LUNDELL I LARHAMMAR D
Citation: Dr. Gehlert et al., CHARACTERIZATION OF THE PEPTIDE BINDING REQUIREMENTS FOR THE CLONED HUMAN PANCREATIC POLYPEPTIDE-PREFERRING RECEPTOR, Molecular pharmacology, 50(1), 1996, pp. 112-118

Authors: BRUNICARDI FC CHAIKEN RL RYAN AS SEYMOUR NE HOFFMANN JA LEBOVITZ HE CHANCE RE GINGERICH RL ANDERSEN DK ELAHI D
Citation: Fc. Brunicardi et al., PANCREATIC-POLYPEPTIDE ADMINISTRATION IMPROVES ABNORMAL GLUCOSE-METABOLISM IN PATIENTS WITH CHRONIC-PANCREATITIS, The Journal of clinical endocrinology and metabolism, 81(10), 1996, pp. 3566-3572

Authors: HUA QX GOZANI SN CHANCE RE FRANK JA WEISS MA
Citation: Qx. Hua et al., STRUCTURE OF A PROTEIN IN A KINETIC TRAP, Nature structural biology, 2(2), 1995, pp. 129-138

Authors: DIMARCHI RD CHANCE RE LONG HB SHIELDS JE SLIKER LJ
Citation: Rd. Dimarchi et al., PREPARATION OF AN INSULIN WITH IMPROVED PHARMACOKINETICS RELATIVE TO HUMAN INSULIN THROUGH CONSIDERATION OF STRUCTURAL HOMOLOGY WITH INSULIN-LIKE GROWTH-FACTOR-I, Hormone research, 41, 1994, pp. 93-96

Authors: GALLOWAY JA CHANCE RE
Citation: Ja. Galloway et Re. Chance, IMPROVING INSULIN THERAPY - ACHIEVEMENTS AND CHALLENGES, Hormone and Metabolic Research, 26(12), 1994, pp. 591-598

Authors: BERNTSON GG ZIPF WB ODORISIO TM HOFFMAN JA CHANCE RE
Citation: Gg. Berntson et al., PANCREATIC-POLYPEPTIDE INFUSIONS REDUCE FOOD-INTAKE IN PRADER-WILLI SYNDROME, Peptides, 14(3), 1993, pp. 497-503

Authors: CHANCE RE FRANK BH
Citation: Re. Chance et Bh. Frank, RESEARCH, DEVELOPMENT, PRODUCTION, AND SAFETY OF BIOSYNTHETIC HUMAN INSULIN, Diabetes care, 16, 1993, pp. 133-142

Authors: HOFFMANN JA CHANCE RE CUSICK T RABE CA TINSLEY FC WILLIAMS VK MYERS SR
Citation: Ja. Hoffmann et al., SYNTHESIS AND BIOACTIVITY OF DES(64,65)-HUMAN PROINSULIN (D), A SOLUBLE, INTERMEDIATE-ACTING INSULIN AGONIST, Diabetes, 42, 1993, pp. 54-54

Authors: RADZIUK J DAVIES J PYE S DIMARCHI RD SHIELDS JE CHANCE RE
Citation: J. Radziuk et al., KINETICS OF SUBCUTANEOUS ABSORPTION AND BIOEFFECTIVENESS OF FAST-ACTING INSULIN ANALOGS, Diabetes, 42, 1993, pp. 205-205
Risultati: 1-16 |